Drug Shortage Report for TOUJEO SOLOSTAR

Last updated on 2022-10-20 History
Report ID 172090
Drug Identification Number 02441829
Brand name TOUJEO SOLOSTAR
Common or Proper name TOUJEO SOLOSTAR
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) INSULIN GLARGINE
Strength(s) 300UNIT
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 5
ATC code A10AE
ATC description INSULINS AND ANALOGUES
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2022-10-18
Estimated end date 2022-10-25
Actual end date 2022-10-19
Shortage status Resolved
Updated date 2022-10-20
Company comments Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2022-10-20 English Compare
v5 2022-10-19 French Compare
v4 2022-10-19 English Compare
v3 2022-10-19 English Compare
v2 2022-10-18 French Compare
v1 2022-10-18 English Compare

Showing 1 to 6 of 6